dc.contributor.author | de Freitas Almeida, Gabriel Magno | |
dc.contributor.author | Sundberg, Lotta-Riina | |
dc.date.accessioned | 2020-05-04T10:15:42Z | |
dc.date.available | 2020-05-04T10:15:42Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | de Freitas Almeida, G. M., & Sundberg, L.-R. (2020). The forgotten tale of Brazilian phage therapy. <i>The Lancet Infectious Diseases</i>, <i>20</i>(5), e90-e101. <a href="https://doi.org/10.1016/S1473-3099(20)30060-8" target="_blank">https://doi.org/10.1016/S1473-3099(20)30060-8</a> | |
dc.identifier.other | CONVID_35102550 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/68812 | |
dc.description.abstract | The use of bacteriophages to treat bacterial infections (known as phage therapy) is considered a possible solution to the antimicrobial resistance crisis. However, phage therapy is not a new concept. The discovery of phages in the early 20th century was closely tied to clinical practice, and phage therapy quickly spread around the world. The use of phage therapy in South America in the previous century is still shrouded in mystery and has been mentioned only briefly in recent scientific literature. Research on Brazilian reference collections of medical texts showed that Brazil was an important, but so far little-known, player of phage therapy, uncovering interesting priority claims and missing pieces of phage therapy history. Of note, there is the widespread use of phages against bacillary dysentery and staphylococcal infections, with José da Costa Cruz from the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) as Brazil's leading expert and pioneer. This Historical Review about historical phage use in Brazil fills the gaps in our knowledge about the so-called golden years of phage therapy, providing information about successful experiences that can be useful against dangerous pathogens in our time. | en |
dc.format.mimetype | application/pdf | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartofseries | The Lancet Infectious Diseases | |
dc.rights | CC BY-NC-ND 4.0 | |
dc.subject.other | Brasilia | |
dc.subject.other | bacteriophages | |
dc.subject.other | bacterial infections | |
dc.subject.other | phage therapy | |
dc.subject.other | Brazil | |
dc.title | The forgotten tale of Brazilian phage therapy | |
dc.type | review article | |
dc.identifier.urn | URN:NBN:fi:jyu-202005043032 | |
dc.contributor.laitos | Bio- ja ympäristötieteiden laitos | fi |
dc.contributor.laitos | Department of Biological and Environmental Science | en |
dc.contributor.oppiaine | Nanoscience Center | fi |
dc.contributor.oppiaine | Solu- ja molekyylibiologia | fi |
dc.contributor.oppiaine | Nanoscience Center | en |
dc.contributor.oppiaine | Cell and Molecular Biology | en |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
dc.type.coar | http://purl.org/coar/resource_type/c_dcae04bc | |
dc.description.reviewstatus | peerReviewed | |
dc.format.pagerange | e90-e101 | |
dc.relation.issn | 1473-3099 | |
dc.relation.numberinseries | 5 | |
dc.relation.volume | 20 | |
dc.type.version | acceptedVersion | |
dc.rights.copyright | © 2020 Elsevier Ltd. All rights reserved. | |
dc.rights.accesslevel | openAccess | fi |
dc.type.publication | article | |
dc.relation.grantnumber | 314939 | |
dc.subject.yso | fagiterapia | |
dc.subject.yso | bakteeritaudit | |
dc.subject.yso | bakteriofagit | |
dc.subject.yso | tutkimushistoria | |
dc.subject.yso | oppihistoria | |
dc.format.content | fulltext | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p29496 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p19293 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p25303 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p21028 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p16329 | |
dc.rights.url | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.relation.doi | 10.1016/S1473-3099(20)30060-8 | |
dc.relation.funder | Research Council of Finland | en |
dc.relation.funder | Suomen Akatemia | fi |
jyx.fundingprogram | Academy Project, AoF | en |
jyx.fundingprogram | Akatemiahanke, SA | fi |
jyx.fundinginformation | This study was funded by the Academy of Finland (grant #314939) and by the Jane and Aatos Erkko Foundation. This work resulted from the BONUS FLAVOPHAGE project supported by BONUS (Art 185), funded jointly by the EU and Academy of Finland | |
dc.type.okm | A2 | |